Trials / Completed
CompletedNCT04673877
Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration
Tissue Concentrations of Vancomycin Achieved With Bier Block Administration Versus Intravenous Prophylaxis in Upper Extremity Surgery: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (upper extremity) is more effective at preventing infection than the current standard dose which is given intravenously (IV).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Systemic IV Vancomycin | 1 g of vancomycin will be delivered intravenously over a period of one hour prior to tourniquet inflation. |
| PROCEDURE | Bier Block | After exsanguination of the limb and elevation of the tourniquet in the prepped and draped patient, Vancomycin will be injected into a superficial vein in the hand, wrist or forearm. |
| DRUG | Vancomycin | 500 mg diluted in 50 cc normal saline of injection into superficial vein in the hand, wrist or forearm |
Timeline
- Start date
- 2021-08-26
- Primary completion
- 2022-08-17
- Completion
- 2022-08-17
- First posted
- 2020-12-17
- Last updated
- 2022-10-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04673877. Inclusion in this directory is not an endorsement.